Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launched

SHKK released its performance for the first three quarters, with a net profit attributable to the parent company of 12.87 million yuan, a year-on-year decrease of 62.81%

According to the Zhitong Finance APP, SHKK disclosed its third-quarter report for 2025. The company achieved revenue of 825 million yuan in the first three quarters, a year-on-year increase of 10.76%; the net profit attributable to the parent company was 12.87 million yuan, a year-on-year decrease of 62.81%; the net profit excluding non-recurring gains and losses was 160,000 yuan, a year-on-year decrease of 87.35%; and the basic earnings per share were 0.052 yuan

The pharmaceutical commercial sector experiences a surge, China Meheco hits the daily limit up

The pharmaceutical commercial sector experienced a surge, with China Meheco hitting the daily limit, followed by Liuyao Group, SYPM, SHKK, LBX, and Hezong Medicine Easy-To-Buy Pharmaceutical rising in tandem

SHKK released its performance for the first half of the year, with a net profit attributable to the parent company of 11.801 million yuan, a year-on-year decrease of 61.94%

SHKK released its 2025 semi-annual report, reporting an operating income of 543 million yuan, a year-on-year increase of 10.95%. The net profit attributable to the parent company was 11.801 million yuan, a year-on-year decrease of 61.94%; the net profit after deducting non-recurring gains and losses was 3.0084 million yuan, a year-on-year decrease of 8.67%. The basic earnings per share were 0.049 yuan

SHKK plans to publicly list and transfer 11.11% equity of Nanjing Tianshi

According to the Zhitong Finance APP, SHKK announced that the company intends to transfer its 11.11% equity in Nanjing Tianshi Software Technology Co., Ltd. (referred to as "Nanjing Tianshi") through public listing at the Shanghai United Assets and Equity Exchange. The minimum price for this public listing transfer will not be less than 17.4123 million yuan. After the transfer is completed, the company will no longer hold any equity in Nanjing Tianshi